jCyte® Announces Appointment of Dr. Rebecca Kammer as Vice President of Clinical Operations

NEWPORT BEACH, Calif.--(BUSINESS WIRE)--jCyte, Inc., a private biotechnology company dedicated to improving the lives of patients with retinal degenerative diseases, announced today the continued expansion of the Company’s leadership team with the appointment of Dr. Rebecca Kammer as Vice President of Clinical Operations. In her new role, Dr. Kammer will...

Click to view original post